Molecular composition of the alveolar lining fluid in the aging lung

Age

Volumn 36, Issue 3, 2014, Pages 1187-1199

  Moliva, Juan I ^a   Rajaram, Murugesan V S ^a   Sidiki, Sabeen ^a   Sasindran, Smitha J ^a   Guirado, Evelyn ^a   Pan, Xueliang Jeff ^a   Wang, Shu Hua ^a,b   Ross, Patrick ^a   Lafuse, William P ^a   Schlesinger, Larry S ^a   Turner, Joanne ^a   Torrelles, Jordi B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Aging; Alveolar lining fluid; Complement; Inflammation; Surfactant

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE ALPHA; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE BETA; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C7; GAMMA INTERFERON; HYDROLASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ELDERLY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFECTION CONTROL; LUNG ALVEOLAR LINING FLUID; LUNG DISEASE; LUNG FLUID; LUNG LAVAGE; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; OXIDATION; PROTEIN ANALYSIS; WESTERN BLOTTING; ANIMAL; LUNG; LUNG ALVEOLUS; METABOLISM; OXIDATIVE STRESS;

ADULT; AGING; ANIMALS; FEMALE; HUMANS; HYDROLASES; LUNG; MALE; MICE; OXIDATIVE STRESS; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

EID: 84905387043     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-014-9633-4     Document Type: Article

References (75)

1. Arcos J, Sasindran SJ, Fujiwara N, Turner J, Schlesinger LS, Torrelles JB (2011) Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. J Immunol 187:372-381
2. Baylis D, Bartlett D, Patel H, Roberts H (2013) Understanding how we age: insights into inflammaging. Longev Healthspan 2:1-8
3. Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS (2002) Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 169:3565-3573
4. Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S et al (1999) Neutrophil granule proteins in bronchoalveolar lavage fluid fromsubjects with subclinical emphysema. Am J Respir Crit Care Med 159:1985-1991 (Pubitemid 29275073)
5. Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M (2004) Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 24:964-970 (Pubitemid 39642287)
6. Bolger MS, Ross DS, Jiang H, Frank MM, Ghio AJ, Schwartz DA et al (2007) Complement levels and activity in the normal and LPS-injured lung. Am J Physiol Lung Cell Mol Physiol 292:L748-L759 (Pubitemid 46376993)
7. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY et al (2000) Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 275:38848-38855 (Pubitemid 32009222)
8. Burton DGA (2009) Cellular senescence, ageing and disease. Age (Dordr) 31:1-9
9. Busse PJ, Mathur SK (2010) Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol 126:690-699
10. Carlson TK, Brooks M, Meyer D, Henning L, Murugesan V et al (2010) Pulmonary innnate immunity: soluble and cellular host defenses of the lung. In: Marsh C, Tridandapani S, Piper M (eds) Regulation of innate immune function. Transworld Research Network, Kerala, pp 165-211
11. Clay CD, Soni S, Gunn JS, Schlesinger LS (2008) Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol 181:5568-5578
12. Cole FS, Matthews WJ Jr, Rossing TH, Gash DJ, Lichtenberg NA, Pennington JE (1983) Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol 27:153-159 (Pubitemid 13127251)
13. Crowther JE, Kutala VK, Kuppusamy P, Ferguson JS, Beharka AA, Zweier JL et al (2004) Pulmonary surfactant protein a inhibitsmacrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol 172:6866-6874 (Pubitemid 38669125)
14. Cruz-Hervert LP, Garcia-Garcia L, Ferreyra-Reyes L, Bobadilla-del-Valle M, Cano-Arellano B, Canizales-Quintero S et al (2012) Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomes. Age Ageing 41:488-495
15. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G et al (2005) Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 24:55-99 (Pubitemid 40146422)
16. de Vries AC, Schram AW, Tager JM, Batenburg JJ, van Golde LM (1985) A specific acid alpha-glucosidase in lamellar bodies of the human lung. Biochim Biophys Acta 837:230-238 (Pubitemid 16209599)
17. DiAugustine RP (1974) Lung concentric laminar organelle. Hydrolase activity and compositional analysis. J Biol Chem 249:584-593
18. Doria G, D'Agostaro G, Poretti A (1978) Age-dependent variations of antibody avidity. Immunology 35:601-611 (Pubitemid 9029183)
19. Dyer C (2012) The interaction of ageing and lung disease. Chron Respir Dis 9:63-67
20. Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L (2004) Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 200:1613-1622 (Pubitemid 40094185)
21. Edelson JD, Shannon JM, Mason RJ (1988) Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis 138:1268-1275 (Pubitemid 18264502)
22. Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS (1999) Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 163:312-321 (Pubitemid 29295855)
23. Ferguson JS, Weis JJ, Martin JL, Schlesinger LS (2004) Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun 72:2564-2573 (Pubitemid 38542382)
24. Ferguson JS, Martin JL, Azad AK, McCarthy TR, Kang PB, Voelker DR et al (2006) Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun 74:7005-7009 (Pubitemid 44913176)
25. Figueroa JE, Densen P (1991) Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4:359-395 (Pubitemid 21920404)
26. Fragoso CAV, Lee PJ (2012) The aging lung. J Gerontol 67A:233-235
27. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N YAcad Sci 908:244-254 (Pubitemid 30462008)
28. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS (1995) Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 155:5343-5351
29. Geunes-Boyer S, Oliver TN, Janbon G, Lodge JK, Heitman J, Perfect JR et al (2009) Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun 77:2783-2794
30. Gilder H, Haschemeyer RH, Fairclough GF Jr, Mynarcik DC (1981) Isolation and characterization of lamellar body material from rat lung homogenates by continuous linear sucrose gradients. J Lipid Res 22:1277-1285
31. Gupta GS, Gupta A, Gupta RK (2012) Animal lectins: form, functions and clinical applications. Springer, London
32. Hawgood S, Poulain FR (2001) The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 63:495-519 (Pubitemid 32304327)
33. Hayakawa H, Giridhar G, Myrvik QN, Kucera L (1992) Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 51:379
34. Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS (2008) Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol 180:7847-7858
35. Ho E, Karimi GK, Liu CC, Bhindi R, Figtree GA (2013) Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 1:483-491
36. Hook GE (1978) Extracellular hydrolases of the lung. Biochemistry 17:520-528
37. Hook GE, Gilmore LB (1982) Hydrolases of pulmonary lysosomes and lamellar bodies. J Biol Chem 257:9211-9220 (Pubitemid 12001887)
38. Ito K, Barnes PJ (2009) COPD as a disease of accelerated lung aging. Chest 135:173-180
39. Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, Tibesar E et al (2005) The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202:987-999 (Pubitemid 41396898)
40. King RJ (1982) Pulmonary surfactant. J Appl Physiol 53:1-8
41. Laskin DL, Pendino KJ (1995) Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35:655-677
42. Lusuardi M, Capelli A, Carli S, Tacconi MT, Salmona M, Donner CF (1992) Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 59(Suppl 1):28-32
43. Mason RJ (2006) Biology of alveolar type II cells. Respirology 11(Suppl):S12-S15
44. Mauderly JL, Hahn FF (1982) The effects of age on lung function and structure of adult animals. Adv Vet Sci Comp Med 26:35-77
45. Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K (1996) Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 153:1072-1079 (Pubitemid 26081662)
46. Mold C (1999) Role of complement in host defense against bacterial infection. Microbes Infect 1:633-638
47. Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS (2012) Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am J Physiol Lung Cell Mol Physiol 303:L608-L616
48. Notter RH (2000) Lung surfactants: basic science and clinical applications. Marcel Dekker, New York, pp 1-444
49. Notter RH, Tabak SA, Mavis RD (1980) Surface properties of binary mixtures of some pulmonary surfactant components. J Lipid Res 21:10-22 (Pubitemid 10120434)
50. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F (2007) Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 4:e247
51. Postle AD (2008) Phospholipid profiling. In: Griffiths W (ed) Metabolomics, metabonomics, and metabolite profiling. The Royal Society of Chemistry, Cambridge, pp 116-133
52. Rebello CM, Jobe AH, Eisele JW, Ikegami M (1996) Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 154:625-628 (Pubitemid 26327282)
53. Reid KB, Clark H, Palaniyar N (2005) Surfactant and lung inflammation. Thorax 60:620-622 (Pubitemid 41129057)
54. Retini C, Kozel TR, Pietrella D, Monari C, Bistoni F, Vecchiarelli A (2001) Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect Immun 69:6064-6073 (Pubitemid 32885166)
55. Reynolds HY (1987) Lung inflammation: normal host defense or a complication of some diseases? Annu Rev Med 38:295-323
56. Robertson J, Caldwell JR, Castle JR, Waldman RH (1976) Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol 117:900-903
57. Romano AD, Serviddio G, de Matthaeis A, Bellanti F, Vendemiale G (2010) Oxidative stress and aging. J Nephrol 23(Suppl 15):S29-S36
58. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181
59. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA (1990) Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 144:2771-2780 (Pubitemid 20136689)
60. Schunemann HJ, Muti P, Freudenheim JL, Armstrong D, Browne R, Klocke RA et al (1997) Oxidative stress and lung function. Am J Epidemiol 146:939-948 (Pubitemid 27524281)
61. Strunk RC, Eidlen DM, Mason RJ (1988) Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 81:1419-1426
62. Taffet GE, Donohue JF, Altman PR (2014) Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging 9:23-30
63. Tedesco F (2008) Inherited complement deficiencies and bacterial infections. Vaccine 26(Suppl 8):I3-I8
64. Tonks A, Morris RH, Price AJ, Thomas AW, Jones KP, Jackson SK (2001) Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin Exp Immunol 124:86-94 (Pubitemid 32479206)
65. Torrelles JB (2012) Broadening our view about the role of Mycobacterium tuberculosis cell envelope components during infection: a battle for survival. In: Cardona PJ (ed) Understanding tuberculosis - analyzing the origin of Mycobacterium tuberculosis pathogenicity. Intech, Rijeka, pp 1-46
66. Umstead TM, Freeman WM, Chinchilli VM, Phelps DS (2009) Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat. Am J Physiol Lung Cell Mol Physiol 296:L14-L29
67. van Golde LM (1985) Synthesis of surfactant lipids in the adult lung. Annu Rev Physiol 47:765-774
68. Veldhuizen R, Nag K, Orgeig S, Possmayer F (1998) The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408:90-108 (Pubitemid 28517860)
69. Walti H, Polla BS, Bachelet M (1997) Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr Res 41:114-119 (Pubitemid 27008645)
70. Wang SH, Carruthers B, Turner J (2012) The influence of increasing age on susceptibility of the elderly to tuberculosis. Open Longetivity Science 6:73-82
71. Watford WT, Wright JR, Hester CG, Jiang H, Frank MM (2001) Surfactant protein A regulates complement activation. J Immunol 167:6593-6600 (Pubitemid 33081596)
72. Williams MC (2003) Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol 65:669-695
73. Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S et al (2012) Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis 205:1589-1592
74. Young SL, Fram EK, Larson E, Wright JR (1993) Recycling of surfactant lipid and apoprotein-A studied by electron microscopic autoradiography. Am J Physiol Lung Cell Mol Physiol 265:L19-L26 (Pubitemid 23227006)
75. Yu SH, Possmayer F (1996) Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcholine in surface films. J Lipid Res 37:1278-1288